877 related articles for article (PubMed ID: 23848605)
1. Seizure control and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registry.
Battino D; Tomson T; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F;
Epilepsia; 2013 Sep; 54(9):1621-7. PubMed ID: 23848605
[TBL] [Abstract][Full Text] [Related]
2. Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry.
EURAP Study Group
Neurology; 2006 Feb; 66(3):354-60. PubMed ID: 16382034
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F;
Lancet Neurol; 2011 Jul; 10(7):609-17. PubMed ID: 21652013
[TBL] [Abstract][Full Text] [Related]
4. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy.
Tomson T; Perucca E; Battino D
Epilepsia; 2004 Oct; 45(10):1171-5. PubMed ID: 15461670
[TBL] [Abstract][Full Text] [Related]
5. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of the newer antiepileptic drugs in controlling seizures in pregnancy.
Vajda FJ; O'Brien T; Lander C; Graham J; Eadie M
Epilepsia; 2014 Aug; 55(8):1229-34. PubMed ID: 24995555
[TBL] [Abstract][Full Text] [Related]
7. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
Lancet Neurol; 2018 Jun; 17(6):530-538. PubMed ID: 29680205
[TBL] [Abstract][Full Text] [Related]
8. Impact of planning of pregnancy in women with epilepsy on seizure control during pregnancy and on maternal and neonatal outcomes.
Abe K; Hamada H; Yamada T; Obata-Yasuoka M; Minakami H; Yoshikawa H
Seizure; 2014 Feb; 23(2):112-6. PubMed ID: 24183922
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of antiepileptic drug use during pregnancy over a period of 12 years in Spain. Efficacy of the newer antiepileptic drugs lamotrigine, levetiracetam, and oxcarbazepine.
Martinez Ferri M; Peña Mayor P; Perez López-Fraile I; Escartin Siquier A; Martin Moro M; Forcadas Berdusan M;
Neurologia (Engl Ed); 2018 Mar; 33(2):78-84. PubMed ID: 27452623
[TBL] [Abstract][Full Text] [Related]
10. Withdrawal of valproic acid treatment during pregnancy and seizure outcome: Observations from EURAP.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
Epilepsia; 2016 Aug; 57(8):e173-7. PubMed ID: 27319360
[TBL] [Abstract][Full Text] [Related]
11. Do antiepileptic drugs or generalized tonic-clonic seizure frequency increase SUDEP risk? A combined analysis.
Hesdorffer DC; Tomson T; Benn E; Sander JW; Nilsson L; Langan Y; Walczak TS; Beghi E; Brodie MJ; Hauser WA;
Epilepsia; 2012 Feb; 53(2):249-52. PubMed ID: 22191685
[TBL] [Abstract][Full Text] [Related]
12. Epileptic disorders in pregnancy: an overview.
Harden CL; Sethi NK
Curr Opin Obstet Gynecol; 2008 Dec; 20(6):557-62. PubMed ID: 18989131
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy in women who have epilepsy.
Pennell PB
Neurol Clin; 2004 Nov; 22(4):799-820. PubMed ID: 15474768
[TBL] [Abstract][Full Text] [Related]
14. The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months.
Vajda FJ; O'Brien TJ; Hitchcock A; Graham J; Lander C
J Clin Neurosci; 2003 Sep; 10(5):543-9. PubMed ID: 12948456
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy.
Fakhoury TA; Hammer AE; Vuong A; Messenheimer JA
Epilepsy Behav; 2004 Aug; 5(4):532-8. PubMed ID: 15256191
[TBL] [Abstract][Full Text] [Related]
16. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
Zeng K; Wang X; Xi Z; Yan Y
Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
[TBL] [Abstract][Full Text] [Related]
17. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
[TBL] [Abstract][Full Text] [Related]
18. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?
Montouris G; Abou-Khalil B
Epilepsia; 2009 Sep; 50 Suppl 8():16-20. PubMed ID: 19702728
[TBL] [Abstract][Full Text] [Related]
19. AntiEpileptic drug Monitoring in PREgnancy (EMPiRE): a double-blind randomised trial on effectiveness and acceptability of monitoring strategies.
Thangaratinam S; Marlin N; Newton S; Weckesser A; Bagary M; Greenhill L; Rikunenko R; D'Amico M; Rogozińska E; Kelso A; Hard K; Coleman J; Moss N; Roberts T; Middleton L; Dodds J; Pullen A; Eldridge S; Pirie A; Denny E; McCorry D; Khan KS
Health Technol Assess; 2018 May; 22(23):1-152. PubMed ID: 29737274
[TBL] [Abstract][Full Text] [Related]
20. The outcomes of pregnancy in women with untreated epilepsy.
Vajda FJ; O'Brien TJ; Graham J; Lander CM; Eadie MJ
Seizure; 2015 Jan; 24():77-81. PubMed ID: 25218112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
